首页> 外文期刊>Nuclear Medicine Communications >Usefulness of F-18-FDG PET/computed tomography in differentiating between subacute and chronic aortic dissection: initial investigation
【24h】

Usefulness of F-18-FDG PET/computed tomography in differentiating between subacute and chronic aortic dissection: initial investigation

机译:Usefulness of F-18-FDG PET/computed tomography in differentiating between subacute and chronic aortic dissection: initial investigation

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives In the selection of thoracic endovascular repair for aortic dissection (AD), it is important to distinguish between the subacute and chronic phases, but there is no reliable way to distinguish between them in patients with unknown onset of AD. The purpose of this study was to assess the diagnostic performance of 2-[F-18] fluoro-2-deoxy-d-glucose (F-18-FDG)-PET/computed tomography (PET/CT) for discriminating subacute AD from chronic AD. Methods Thirteen patients with AD who were medically treated and followed up for 6 months were studied. F-18-FDG PET/CT images were obtained for each patient in the subacute phase (the first scan) and at 6 months (the second scan) after the onset. Target-to-background ratio (TBR) was measured as the maximum standardized uptake value (SUV) in the dissected aortic wall divided by blood pool SUV. Results TBR was significantly higher in the first scan (mean +/- SD, 1.97 +/- 0.32) than in the second scan (1.69 +/- 0.29, P = 0.007). The area under the receiver operating characteristic curve of TBR for discriminating subacute AD from chronic AD was 0.76. With a threshold of 1.74, the TBR showed the sensitivity, specificity, and positive and negative predictive value of 85%, 69%, 73%, and 82%, respectively, for the discrimination of subacute AD from chronic AD. Conclusion Metabolic assessment of dissected aortic wall by F-18-FDG PET/CT is useful in differentiating between subacute and chronic AD and can provide important information in determining the appropriate indication for treatment for patients with AD of unknown onset.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号